Lisata Therapeutics, Inc. (LSTA)
1.99
+0.13
(+6.99%)
USD |
NASDAQ |
Sep 09, 13:39
Lisata Therapeutics Shareholders Equity (Quarterly) : 8.244M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.244M |
| March 31, 2026 | 10.93M |
| December 31, 2025 | 14.86M |
| September 30, 2025 | 17.37M |
| June 30, 2025 | 21.03M |
| March 31, 2025 | 25.36M |
| December 31, 2024 | 29.57M |
| September 30, 2024 | 33.69M |
| June 30, 2024 | 38.25M |
| March 31, 2024 | 43.00M |
| December 31, 2023 | 48.15M |
| September 30, 2023 | 52.96M |
| June 30, 2023 | 57.97M |
| March 31, 2023 | 60.96M |
| December 31, 2022 | 66.58M |
| September 30, 2022 | 72.02M |
| June 30, 2022 | 82.39M |
| March 31, 2022 | 88.50M |
| December 31, 2021 | 92.25M |
| September 30, 2021 | 98.67M |
| June 30, 2021 | 104.93M |
| March 31, 2021 | 110.27M |
| December 31, 2020 | 32.50M |
| September 30, 2020 | 37.74M |
| June 30, 2020 | 33.81M |
| Date | Value |
|---|---|
| March 31, 2020 | 17.24M |
| December 31, 2019 | 20.82M |
| September 30, 2019 | 25.25M |
| June 30, 2019 | 29.89M |
| March 31, 2019 | 34.73M |
| December 31, 2018 | 37.73M |
| September 30, 2018 | 41.08M |
| June 30, 2018 | 43.74M |
| March 31, 2018 | 45.59M |
| December 31, 2017 | 50.51M |
| September 30, 2017 | 53.33M |
| June 30, 2017 | 54.42M |
| March 31, 2017 | -0.791M |
| December 31, 2016 | 24.28M |
| September 30, 2016 | 10.75M |
| June 30, 2016 | 6.050M |
| March 31, 2016 | 33.06M |
| December 31, 2015 | 23.71M |
| September 30, 2015 | 55.43M |
| June 30, 2015 | 66.38M |
| March 31, 2015 | 50.40M |
| December 31, 2014 | 58.51M |
| September 30, 2014 | 63.00M |
| June 30, 2014 | 78.04M |
| March 31, 2014 | 59.64M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.03M |
| Total Liabilities (Quarterly) | 3.037M |
| Current Ratio | 3.687 |
| Net Debt Paydown Yield | 0.06% |